Compare Morgan Stanley (MS) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs Vital Farms Inc — how do they compare? Morgan Stanley trades at $188.09 (market cap $297.95B), while Vital Farms Inc trades at $9.45 (market cap $396.69M). The key difference: Morgan Stanley is far larger — about 751.1× Vital Farms Inc's market cap, and Morgan Stanley pays a 2.42% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Morgan Stanley for 93 Days and Vital Farms Inc for 14 Days on average.
| MS | VITL | |
|---|---|---|
Market Cap | $297.95B | $396.69M |
Volume | 5,030,247 | 1,219,207 |
Sector | Financials | Consumer Staples |
52-Week High | $228.42 | $43.68 |
52-Week Low | $151.86 | $8.28 |
Typical Hold Time | 93 Days | 14 Days |
Enterprise Value | $663.67B | $483.70M |
Dividend Yield | 2.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $187.41, down 1.86% on the day, with a bearish technical signal but strong fundamentals including a P/E of 15.32 and net income margin of 27.59%. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, rising from $50.2B in 2022 to $66.0B in 2025, and the company highlights growth opportunities in wealth management and AI financing.
The outlook is supported by a bullish analyst consensus with a $229.25 price target, though risks include volatile cash flows and rising debt-to-asset ratios. Near-term price action is testing support near $184, with investor sentiment mixed amid fading capital markets momentum but positive long-term growth narratives.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, amid a bearish technical signal and challenging fundamentals. Recent earnings show volatility with a Q2 2026 loss of $0.47 per share, though it slightly beat expectations, while revenue declined 10% year-over-year in that quarter. The company faces pressure from egg pricing and oversupply, as noted in recent news, but maintains a 'Buy' consensus from analysts with a $13.11 price target.
The outlook is mixed: strong analyst support and potential strategic options like a sale offer upside, but weak profitability margins and cash flow concerns pose significant risks. Investors should weigh the company's market position against ongoing industry headwinds and execution challenges in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
